Why is Vaishali Pharma falling/rising?

As of 24-Jun, Vaishali Pharma Ltd's stock price is currently at 12.07, reflecting a decrease of 0.11, or 0.9%. The stock has underperformed its sector by 1.11% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 4.81%, and it has seen a significant drop of 30.99% year-to-date. Despite a recent increase in delivery volume by 71.85%, the company is facing challenges such as operating losses and a weak ability to service its debt, indicated by a poor EBIT to Interest ratio of 1.57. The stock's negative performance is further highlighted by its return of -26.80% over the past year, alongside a low profitability per unit of shareholders' funds, as evidenced by an average Return on Equity of 8.96%.
In the broader market context, the Sensex has shown a positive return of 0.77% over the past week, contrasting sharply with Vaishali Pharma's decline. This underperformance is evident as the stock has lagged behind the BSE 500 index over the last three years, one year, and three months. The company's flat results and negative operating profits contribute to its classification as a risky investment, which may deter potential investors. Overall, the combination of weak fundamentals, poor short-term performance, and unfavorable market conditions has led to the stock's decline.